MedPath

Tetracaine

TETRACAINE 1% Tetracaine HCl Injection, USP for Prolonged Spinal Anesthesia

Approved
Approval ID

80a96844-f983-4852-8197-a46a5f60461d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 28, 2021

Manufacturers
FDA

Cameron Pharmaceuticals

DUNS: 078371442

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TETRACAINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42494-437
Product Classification
G
Generic Name
TETRACAINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateJuly 28, 2021
FDA Product Classification

INGREDIENTS (5)

TETRACAINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: 5NF5D4OPCI
Classification: ACTIB
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tetracaine - FDA Drug Approval Details